MAGEGAN SAKHIZADA: Open Payments
NPI 1992370738 · STOCKTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$437 in 24 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $390 · 2025 $437
Food & beverage: $437
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 8 | $135 |
| MAYNE PHARMA COMMERCIAL LLC | 7 | $121 |
| Supernus Pharmaceuticals, Inc. | 4 | $84 |
| Astellas Pharma US Inc | 2 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $17 |
Products named: ZURZUVAE, Qelbree, Veozah, MYFEMBREE, Mirena, JOURNAVX.
Industry payments across CA — which companies pay providers there.
